Tweets: MDVN (Medivation)

GaeaPharmaLtd via Twitter 09:50 AM  05/21/13 reply  |  re-tweet

RT @CytoVac: Medivation, XTANDI The wholesale price of the drug is $74.50 for a 30-day supply http://t.co/UFTxtSa8cZ $MDVN (Msgs, Twts)

CytoVac via Twitter 03:21 AM  05/21/13 reply  |  re-tweet

Medivation, XTANDI The wholesale price of the drug is $74.50 for a 30-day supply http://t.co/UFTxtSa8cZ $MDVN (Msgs, Twts)

TomSilver39 via Twitter 12:50 PM  05/19/13 reply  |  re-tweet

$GILD (Msgs, Twts) $CLDX (Msgs, Twts) $ARIA (Msgs, Twts) $MDVN (Msgs, Twts) -top stocks in Biotech Fund http://t.co/MczemtEenk

MikeOinSATX via Twitter 07:26 PM  05/17/13 reply  |  re-tweet

@TInaAlbano2 Every stock you've asked me about has taken off soon after- $MDVN (Msgs, Twts) $AEGR (Msgs, Twts) $TSRO (Msgs, Twts) $THRX (Msgs, Twts). You've a good eye or a good informant. ;-)

MikeOinSATX via Twitter 07:02 PM  05/17/13 reply  |  re-tweet

@TInaAlbano2 Not sure, $MDVN (Msgs, Twts) may be down due to anticipated competition from $BAYRY (Msgs, Twts)'s recently approved Xofigo. $AEGR (Msgs, Twts) - Nice jump yesterday.

BIOTECH888 via Twitter 05:23 PM  05/17/13 reply  |  re-tweet

$MDVN (Msgs, Twts) XTANDI OS 4.8months VS. Bayers XOFIGO OS 2.8months

IPO_Alerts via Twitter 05:24 AM  05/17/13 reply  |  re-tweet

Check out the most widely held #smallcaps $MDVN (Msgs, Twts) $PLT (Msgs, Twts) $MTOR (Msgs, Twts) $UHT (Msgs, Twts) $ONXX (Msgs, Twts) $CPX (Msgs, Twts) $CAVM (Msgs, Twts) $PSSI (Msgs, Twts) $CNQR (Msgs, Twts) $MASI (Msgs, Twts) $BEXP (Msgs, Twts) http://t.co/FwFB9lfQEu

DanielMaika via Twitter 05:14 AM  05/17/13 reply  |  re-tweet

@Jan_Kud $MDVN (Msgs, Twts) weekly/daily deathcross breakdown completed yday, Target 30$ by NOV, hehe #PUTS

PKBFC via Twitter 06:12 PM  05/16/13 reply  |  re-tweet

RT @Mind__Equity: Check out the most widely held #smallcaps $MDVN (Msgs, Twts) $AIR (Msgs, Twts) $ULTI (Msgs, Twts) $CYMI (Msgs, Twts) $DMND (Msgs, Twts) $POL (Msgs, Twts) $IPXL (Msgs, Twts) $PSSI (Msgs, Twts) $GEO (Msgs, Twts) $CROX (Msgs, Twts) $WCC (Msgs, Twts) http://t.co/6uWd3wL70d

Mind__Equity via Twitter 06:11 PM  05/16/13 reply  |  re-tweet

Check out the most widely held #smallcaps $MDVN (Msgs, Twts) $AIR (Msgs, Twts) $ULTI (Msgs, Twts) $CYMI (Msgs, Twts) $DMND (Msgs, Twts) $POL (Msgs, Twts) $IPXL (Msgs, Twts) $PSSI (Msgs, Twts) $GEO (Msgs, Twts) $CROX (Msgs, Twts) $WCC (Msgs, Twts) http://t.co/6uWd3wL70d

janechin via Twitter 02:21 PM  05/16/13 reply  |  re-tweet

@Quantumandlotus we will see next week! I don't really care about the $MDVN (Msgs, Twts) downgrade :)

Quantumandlotus via Twitter 02:20 PM  05/16/13 reply  |  re-tweet

@janechin $MDVN (Msgs, Twts) could be trading side ways but looks like it can go ether way right now. :)

janechin via Twitter 02:17 PM  05/16/13 reply  |  re-tweet

@Quantumandlotus I went after $MDVN (Msgs, Twts) during the dip.

chasingthealpha via Twitter 09:10 AM  05/16/13 reply  |  re-tweet

Good ole nipple pain as an AE, thats a new one, $MDVN (Msgs, Twts) Xtandi hormone naive data look good - http://t.co/QwZLjGYeOC

rdittamore via Twitter 10:47 PM  05/15/13 reply  |  re-tweet

@adamfeuerstein @BiotechStockRsr neither $MDVN (Msgs, Twts) nor $EXEL (Msgs, Twts) should be hurt too bad. Different MOAs for diff pts and stages of mCRPC.

griffoncanisius via Twitter 07:21 PM  05/15/13 reply  |  re-tweet

@BiotechStockRsr. Rad223 won't impact xtandi . We have ~10 patients that we will infuse starting ASAP. All are on xtandi now $MDVN (Msgs, Twts)

BiotechStockRsr via Twitter 04:43 PM  05/15/13 reply  |  re-tweet

@chasingthealpha Cowen is the poster child, to be sure, but there are others clearly as clueless. $MDVN (Msgs, Twts)

pharmacreep via Twitter 04:42 PM  05/15/13 reply  |  re-tweet

RT @BiotechStockRsr: Anyone who thinks the $BAY (Msgs, Twts) Alpharadin approval hurts $MDVN (Msgs, Twts) really needs to find a different research provider.

adamfeuerstein via Twitter 04:29 PM  05/15/13 reply  |  re-tweet

@BiotechStockRsr If $BAY (Msgs, Twts) can sell Alpharadin, $EXEL (Msgs, Twts) is the stock that is hurt, not $MDVN (Msgs, Twts). But I shouldn't be telling the PrC god anything!

chasingthealpha via Twitter 04:28 PM  05/15/13 reply  |  re-tweet

RT @BiotechStockRsr: Anyone who thinks the $BAY (Msgs, Twts) Alpharadin approval hurts $MDVN (Msgs, Twts) really needs to find a different research provider.

BiotechStockRsr via Twitter 04:26 PM  05/15/13 reply  |  re-tweet

Anyone who thinks the $BAY (Msgs, Twts) Alpharadin approval hurts $MDVN (Msgs, Twts) really needs to find a different research provider.

ScienceMonitor via Twitter 02:30 PM  05/15/13 reply  |  re-tweet

RT @ScripDonnaDC: #FDA OK's Bayer Xofigo for symptomatic metastatic CRPC http://t.co/vljm80CmiA #pharma #biotech #biopharma $MDVN (Msgs, Twts)

PharmaMarketAcc via Twitter 12:31 PM  05/15/13 reply  |  re-tweet

RT @ScripDonnaDC: #FDA OK's Bayer Xofigo for symptomatic metastatic CRPC http://t.co/vljm80CmiA #pharma #biotech #biopharma $MDVN (Msgs, Twts)

scripnews via Twitter 11:52 AM  05/15/13 reply  |  re-tweet

RT @ScripDonnaDC: #FDA OK's Bayer Xofigo for symptomatic metastatic CRPC http://t.co/vljm80CmiA #pharma #biotech #biopharma $MDVN (Msgs, Twts)

ScripAlexS via Twitter 11:48 AM  05/15/13 reply  |  re-tweet

RT @scripdonnadc: #FDA OK's Bayer Xofigo for symptomatic metastatic CRPC http://t.co/ohPYKxkVTd #pharma #biotech #biopharma $MDVN (Msgs, Twts)